Birdwatch Note Rating
2023-04-03 20:22:05 UTC - HELPFUL
Rated by Participant: BF1F5EAFDBED5930089B070C43E5580B9E67840281B4463F10DA9EE4A039E391
Participant Details
Original Note:
Three doses of BNT162b2 have a vaccine effectiveness of 73.5% against mild or moderate disease in adults aged 20–59 years, 98.6% protection against severe disease https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext#tbl2 The 3-dose VE against hospitalization was 97.5%, 82.0%, and 72.4%, respectively. https://www.medrxiv.org/content/10.1101/2022.09.30.22280573v2
All Note Details